Hyperoxia Toxicity in Septic Shock Patients According to the Sepsis-3 Criteria: A Post Hoc Analysis of the HYPER2S Trial

Annals of Intensive Care - Germany
doi 10.1186/s13613-018-0435-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Pentraxin 3 in Patients With Severe Sepsis or Shock: The ALBIOS Trial

European Journal of Clinical Investigation
MedicineBiochemistryClinical Biochemistry
2016English

Sepsis and Septic Shock

Anaesthesia, Pain and Intensive Care
Critical CareAnesthesiologyPain MedicineIntensive Care Medicine
2020English

Plasmapheresis in Severe Sepsis and Septic Shock: A Prospective, Randomised, Controlled Trial

Intensive Care Medicine
Critical CareIntensive Care Medicine
2002English

Baseline Characteristics of Patients With and Without Hypercoaguable Sepsis and the Effect of Afelimomab on Mortality: A Post Hoc Analysis From the MONARCS Trial

Critical Care
Critical CareIntensive Care Medicine
2001English

Vasoplegia in Patients With Sepsis and Septic Shock: Pathways and Mechanisms

Journal of International Medical Research
BiochemistryMedicineCell Biology
2018English

Correction To: Polymyxin B-Immobilized Hemoperfusion and Mortality in Critically Ill Adult Patients With Sepsis/Septic Shock: A Systematic Review With Meta-Analysis and Trial Sequential Analysis

Intensive Care Medicine
Critical CareIntensive Care Medicine
2018English

Prevalence of Antimicrobial Resistant Pathogens in Severe Sepsis and Septic Shock Patients

Journal of Young Pharmacists
ToxicologyPharmaceuticsPharmacology
2018English

Relation of Echocardiographic Parameters to Outcome of Patients With Severe Sepsis and Septic Shock

Journal of Cardiovascular Disease Research
Cardiovascular MedicineCardiology
2017English

Sepsis, Severe Sepsis and Septic Shock in Adults and Anaesthesia

Southern African Journal of Anaesthesia and Analgesia
AnesthesiologyPain Medicine
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy